| 2026-11-16 Filed 2026-11-17 | THORNTON JOSEPH CLAY Officer: Chief Financial Officer | S Open market or private sale of non-derivative or derivative security Class A Common Stock | Disposed (D) | 22,099 | 4.97 | 109,832.03 Derived: shares × price per share. Exact value 109832.03. | 1,551,783 | Direct (D) | No | — | Open filing 0001801170-26-000311 Read from the filing’s XML Dispute this row |
| 2026-11-04 Filed 2026-11-06 | OLDAKOWSKI JOSEPH FRANK Officer: Chief Accounting Officer | A Grant, award or other acquisition pursuant to Rule 16b-3(d) Class A Common Stock | Acquired (A) | 186,403 | 0 | — | 462,300 | Direct (D) | No | F1 - F1 Represents shares of Class A common stock underlying a time-based restricted stock unit award (RSUs). Twenty-five percent of the RSUs will vest on the first anniversary of November 4, 2026, and the remaining RSUs will vest in twelve equal quarterly installments beginning on the date that is three months after the first anniversary of November 4, 2026, in each case subject to the continued service of the Reporting Person on each such vesting date, so that such RSUs will be fully vested on November 4, 2030.
| Open filing 0001801170-26-000299 Read from the filing’s XML Dispute this row |
| 2026-11-04 Filed 2026-11-06 | THORNTON JOSEPH CLAY Officer: Chief Financial Officer | A Grant, award or other acquisition pursuant to Rule 16b-3(d) Class A Common Stock | Acquired (A) | 328,947 | 0 | — | 1,573,882 | Direct (D) | No | F1 - F1 Represents shares of Class A common stock underlying a time-based restricted stock unit award (RSUs). Twenty-five percent of the RSUs will vest on the first anniversary of November 4, 2026, and the remaining RSUs will vest in twelve equal quarterly installments beginning on the date that is three months after the first anniversary of November 4, 2026, in each case subject to the continued service of the Reporting Person on each such vesting date, so that such RSUs will be fully vested on November 4, 2030.
| Open filing 0001801170-26-000298 Read from the filing’s XML Dispute this row |
| 2026-10-20 Filed 2026-10-20 | Soares Karen Officer: Chief Legal Officer | S Open market or private sale of non-derivative or derivative security Class A Common Stock | Disposed (D) | 19,275 | 4.66 | 89,821.5 Derived: shares × price per share. Exact value 89821.50. | 1,573,423 | Direct (D) | Yes | F1, F2 - F1 The sales reported in this Form 4 were effected pursuant to a 10b5-1 plan adopted by the Reporting Person on March 13, 2026.
- F2 The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $4.45 to $4.79, inclusive. The Reporting Person undertakes to provide to the Issuer, any securityholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (2) to this Form 4.
| Open filing 0001999086-26-000034 Read from the filing’s XML Dispute this row |
| 2026-10-19 Filed 2026-10-20 | Reynoso Jamie L. Officer: CEO, Medicare Advantage | S Open market or private sale of non-derivative or derivative security Class A Common Stock | Disposed (D) | 4,066 | 4.41 | 17,931.06 Derived: shares × price per share. Exact value 17931.06. | 2,770,351 | Direct (D) | Yes | F1, F2 - F1 The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 12, 2026.
- F2 The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $4.32 to $4.54, inclusive. The Reporting Person undertakes to provide to the Issuer, any securityholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (2) to this Form 4.
| Open filing 0001839066-26-000057 Read from the filing’s XML Dispute this row |
| 2026-10-15 Filed 2026-10-19 | THORNTON JOSEPH CLAY Officer: Interim CFO | S Open market or private sale of non-derivative or derivative security Class A Common Stock | Disposed (D) | 4,591 | 4.68 | 21,485.88 Derived: shares × price per share. Exact value 21485.88. | 1,244,935 | Direct (D) | Yes | F1, F2 - F1 The sales reported on this Form 4 represent shares of Class A Common Stock required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of 6.25% of restricted stock units (the RSUs) on October 15, 2026. The RSUs were originally granted to the Reporting Person on October 15, 2024. The remaining RSUs vest quarterly in equal installments of 6.25%, with the final vesting date occurring on October 15, 2028, subject to the continued service of the Reporting Person on each such vesting date. These sales are mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a sell to cover transaction and do not represent discretionary trades by the Reporting Person.
- F2 The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $4.67 to $4.68, inclusive. The Reporting Person undertakes to provide to the Issuer, any securityholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (2) to this Form 4.
| Open filing 0001801170-26-000280 Read from the filing’s XML Dispute this row |
| 2026-10-15 Filed 2026-10-19 | Wai Conrad Officer: CEO, Counterpart Health | S Open market or private sale of non-derivative or derivative security Class A Common Stock | Disposed (D) | 23,627 | 4.68 | 110,574.36 Derived: shares × price per share. Exact value 110574.36. | 1,042,072 | Direct (D) | Yes | F1, F2 - F1 The sales reported on this Form 4 represent shares of Class A Common Stock required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of 6.25% of restricted stock units (RSUs) originally granted to the Reporting Person on October 15, 2024. The remaining RSUs vest quarterly in equal installments of 6.25%, with the final vesting date occurring on October 15, 2028, subject to the continued service of the Reporting Person on each such vesting date. These sales are mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a sell to cover transaction and do not represent discretionary trades by the Reporting Person.
- F2 The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $4.67 to $4.68, inclusive. The Reporting Person undertakes to provide to the Issuer, any securityholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (2) to this Form 4.
| Open filing 0001801170-26-000278 Read from the filing’s XML Dispute this row |
| 2026-10-15 Filed 2026-10-19 | Toy Andrew Director · Officer: Chief Executive Officer | S Open market or private sale of non-derivative or derivative security Class A Common Stock | Disposed (D) | 62,176 | 4.68 | 290,983.68 Derived: shares × price per share. Exact value 290983.68. | 9,078,334 | Direct (D) | Yes | F1, F2 - F1 The sales reported on this Form 4 represent shares of Class A Common Stock required to be sold by the Reporting Person to cover tax withholding obligations in connection with the quarterly vesting on October 15, 2026 of 6.25% of restricted stock units originally granted to the Reporting Person on October 15, 2024. The restricted stock units vest quarterly, with a final vesting on October 15, 2028, subject to the continued service of the Reporting Person on each such vesting date. These sales are mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a sell to cover transaction and do not represent discretionary trades by the Reporting Person.
- F2 The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $4.67 to $4.68, inclusive. The Reporting Person undertakes to provide to the Issuer, any securityholder of the Issuer, or the staff of the Securities and Exchange Commission (the SEC), upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (2) to this Form 4.
| Open filing 0001801170-26-000284 Read from the filing’s XML Dispute this row |
| 2026-10-15 Filed 2026-10-19 | Soares Karen Officer: Chief Legal Officer | S Open market or private sale of non-derivative or derivative security Class A Common Stock | Disposed (D) | 14,673 | 4.68 | 68,669.64 Derived: shares × price per share. Exact value 68669.64. | 1,592,698 | Direct (D) | Yes | F1, F2 - F1 The sales reported on this Form 4 represent shares of Class A Common Stock required to be sold by the Reporting Person to cover tax withholding obligations in connection with the quarterly vesting on October 15, 2026 of 6.25% of restricted stock units originally granted to the Reporting Person on October 15, 2024. The restricted stock units vest quarterly, with a final vesting on October 15, 2028, subject to the continued service of the Reporting Person on each such vesting date. These sales are mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a sell to cover transaction and do not represent discretionary trades by the Reporting Person.
- F2 The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $4.67 to $4.68, inclusive. The Reporting Person undertakes to provide to the Issuer, any securityholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (2) to this Form 4.
| Open filing 0001801170-26-000282 Read from the filing’s XML Dispute this row |
| 2026-10-15 Filed 2026-10-19 | Reynoso Jamie L. Officer: CEO, Medicare Advantage | S Open market or private sale of non-derivative or derivative security Class A Common Stock | Disposed (D) | 18,273 | 4.68 | 85,517.64 Derived: shares × price per share. Exact value 85517.64. | 2,774,417 | Direct (D) | Yes | F1, F2 - F1 The sales reported on this Form 4 represent shares of Class A Common Stock required to be sold by the Reporting Person to cover tax withholding obligations in connection with the quarterly vesting on October 15, 2026 of 6.25% of restricted stock units originally granted to the Reporting Person on October 15, 2024. The restricted stock units vest quarterly, with a final vesting on October 15, 2028, subject to the continued service of the Reporting Person on each such vesting date. These sales are mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a sell to cover transaction and do not represent discretionary trades by the Reporting Person.
- F2 The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $4.67 to $4.68, inclusive. The Reporting Person undertakes to provide to the Issuer, any securityholder of the Issuer, or the staff of the Securities and Exchange Commission (the SEC), upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (2) to this Form 4.
| Open filing 0001801170-26-000276 Read from the filing’s XML Dispute this row |
| 2026-10-07 Filed 2026-10-07 | Reynoso Jamie L. Officer: CEO, Medicare Advantage | S Open market or private sale of non-derivative or derivative security Class A Common Stock | Disposed (D) | 2,006 | 4.63 | 9,287.78 Derived: shares × price per share. Exact value 9287.78. | 2,792,690 | Direct (D) | Yes | F1, F2 - F1 The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 12, 2026.
- F2 The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $4.54 to $4.72, inclusive. The Reporting Person undertakes to provide to the Issuer, any securityholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (2) to this Form 4.
| Open filing 0001839066-26-000054 Read from the filing’s XML Dispute this row |
| 2026-10-05 Filed 2026-10-05 | Reynoso Jamie L. Officer: CEO, Medicare Advantage | S Open market or private sale of non-derivative or derivative security Class A Common Stock | Disposed (D) | 8,750 | 4.42 | 38,675 Derived: shares × price per share. Exact value 38675.00. | 2,794,696 | Direct (D) | Yes | F1 - F1 The sales reported on this Form 4 represent shares of Class A Common Stock required to be sold by the Reporting Person to cover tax withholding obligations in connection with the quarterly vesting of 6.25% of restricted stock units (the RSUs) on October 3, 2026. The RSUs were originally granted to the Reporting Person on January 3, 2023, with a final vesting on January 3, 2027, subject to the continued service of the Reporting Person on such final vesting date. These sales are mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a sell to cover transaction and do not represent discretionary trades by the Reporting Person.
| Open filing 0001839066-26-000052 Read from the filing’s XML Dispute this row |
| 2026-10-01 Filed 2026-10-02 | Toy Andrew Director · Officer: Chief Executive Officer | S Open market or private sale of non-derivative or derivative security Class A Common Stock | Disposed (D) | 318,806 | 4.19 | 1,335,797.14 Derived: shares × price per share. Exact value 1335797.14. | 9,140,510 | Direct (D) | Yes | F1, F2 - F1 The sales reported on this Form 4 represent shares of Class A Common Stock required to be sold by the Reporting Person to cover tax withholding obligations in connection with the quarterly vesting on October 1, 2026 of 6.25% of restricted stock units originally granted to the Reporting Person on January 1, 2023. These sales are mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a sell to cover transaction and do not represent discretionary trades by the Reporting Person.
- F2 The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $4.18 to $4.21, inclusive. The Reporting Person undertakes to provide to the Issuer, any securityholder of the Issuer, or the staff of the Securities and Exchange Commission (the SEC), upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (2) to this Form 4.
| Open filing 0001801170-26-000242 Read from the filing’s XML Dispute this row |
| 2026-09-30 Filed 2026-10-02 | Torricelli Robert G Director | A Grant, award or other acquisition pursuant to Rule 16b-3(d) Class A Common Stock | Acquired (A) | 12,481 | 0 | — | 186,897 | Direct (D) | No | F1 - F1 Represents shares of Class A common stock of Clover Health Investments, Corp. (the Company) underlying a time-based restricted stock unit award (RSUs) granted to the Reporting Person on September 30, 2026. The RSUs will vest in full on the first anniversary of September 30, 2026 subject to the Reporting Person's continued service as a member of the Company's Board of Directors through such vesting date.
| Open filing 0001801170-26-000243 Read from the filing’s XML Dispute this row |
| 2026-09-30 Filed 2026-10-02 | Miller Brian James Director | A Grant, award or other acquisition pursuant to Rule 16b-3(d) Class A Common Stock | Acquired (A) | 12,481 | 0 | — | 12,481 | Direct (D) | No | F1 - F1 Represents shares of Class A common stock of Clover Health Investments, Corp. (the Company) underlying a time-based restricted stock unit award (RSUs) granted to the Reporting Person on September 30, 2026. The RSUs will vest in full on the first anniversary of September 30, 2026 subject to the Reporting Person's continued service as a member of the Company's Board of Directors through such vesting date.
| Open filing 0001801170-26-000244 Read from the filing’s XML Dispute this row |
| 2026-09-17 Filed 2026-09-18 | Reynoso Jamie L. Officer: CEO, Medicare Advantage | S Open market or private sale of non-derivative or derivative security Class A Common Stock | Disposed (D) | 1,921 | 4.56 | 8,759.76 Derived: shares × price per share. Exact value 8759.76. | 2,803,446 | Direct (D) | Yes | F1 - F1 The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 12, 2026.
| Open filing 0001839066-26-000047 Read from the filing’s XML Dispute this row |
| 2026-09-16 Filed 2026-09-17 | OLDAKOWSKI JOSEPH FRANK Officer: VP OF FINANCE AND CONTROLLER | S Open market or private sale of non-derivative or derivative security Class A Common Stock | Disposed (D) | 3,170 | 4.64 | 14,708.8 Derived: shares × price per share. Exact value 14708.80. | 275,897 | Direct (D) | Yes | F1 - F1 The sales reported on this Form 4 represent shares of Class A Common Stock required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of 6.25% of restricted stock units (RSUs) originally granted to the Reporting Person on June 16, 2025. The remaining RSUs vest quarterly in equal installments of 6.25%, with the final vesting date occurring on June 16, 2029, subject to the continued service of the Reporting Person on each such vesting date. These sales are mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a sell to cover transaction and do not represent discretionary trades by the Reporting Person.
| Open filing 0001801170-26-000223 Read from the filing’s XML Dispute this row |
| 2026-09-15 Filed 2026-09-16 | Wai Conrad Officer: CEO, Counterpart Health | S Open market or private sale of non-derivative or derivative security Class A Common Stock | Disposed (D) | 300,000 | 4.72 | 1,416,000 Derived: shares × price per share. Exact value 1416000.00. | 1,170,056 | Indirect (I) By Trust. | Yes | F1, F2 - F1 The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 8, 2026. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $4.60 to $5.06, inclusive. The Reporting Person undertakes to provide to the Securities and Exchange Commission staff, the issuer, or any security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
- F2 Shares held in trust for the benefit of the Reporting Person's family, of which the Reporting Person is a co-trustee.
| Open filing 0001971702-26-000017 Read from the filing’s XML Dispute this row |
| 2026-09-15 Filed 2026-09-15 | Reynoso Jamie L. Officer: CEO, Medicare Advantage | S Open market or private sale of non-derivative or derivative security Class A Common Stock | Disposed (D) | 9,273 | 4.78 | 44,324.94 Derived: shares × price per share. Exact value 44324.94. | 2,805,367 | Direct (D) | Yes | F1, F2 - F1 The sales reported on this Form 4 represent shares of Class A Common Stock required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of the final 6.25% of restricted stock units (the RSUs) on September 15, 2026. The RSUs were originally granted to the Reporting Person on September 16, 2022. These sales are mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a sell to cover transaction and do not represent discretionary trades by the Reporting Person.
- F2 The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $4.70 to $4.78, inclusive. The Reporting Person undertakes to provide to the Issuer, any securityholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (2) to this Form 4.
| Open filing 0001839066-26-000045 Read from the filing’s XML Dispute this row |
| 2026-09-15 Filed 2026-09-15 | Soares Karen Officer: Chief Legal Officer | S Open market or private sale of non-derivative or derivative security Class A Common Stock | Disposed (D) | 6,846 | 4.78 | 32,723.88 Derived: shares × price per share. Exact value 32723.88. | 1,607,371 | Direct (D) | Yes | F1, F2 - F1 The sales reported on this Form 4 represent shares of Common Stock required to be sold by the Reporting Person to cover tax withholding obligations in connection with the final vesting of 6.25% of restricted stock units originally granted to the Reporting Person on September 15, 2022. These sales are mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a sell to cover transaction and do not represent discretionary trades by the Reporting Person.
- F2 The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $4.70 to $4.78, inclusive. The Reporting Person undertakes to provide to the Issuer, any securityholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (2) to this Form 4.
| Open filing 0001999086-26-000031 Read from the filing’s XML Dispute this row |
| 2026-09-14 Filed 2026-09-14 | OLDAKOWSKI JOSEPH FRANK Officer: VP OF FINANCE AND CONTROLLER | S Open market or private sale of non-derivative or derivative security Class A Common Stock | Disposed (D) | 20,000 | 5.16 | 103,200 Derived: shares × price per share. Exact value 103200.00. | 279,067 | Direct (D) | No | — | Open filing 0001801170-26-000218 Read from the filing’s XML Dispute this row |
| 2026-08-17 Filed 2026-08-17 | THORNTON JOSEPH CLAY Officer: Interim CFO | S Open market or private sale of non-derivative or derivative security Class A Common Stock | Disposed (D) | 17,775 | 4.39 | 78,032.25 Derived: shares × price per share. Exact value 78032.25. | 1,249,526 | Direct (D) | Yes | F1, F2 - F1 The sales reported on this Form 4 represent shares of Class A Common Stock required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of 6.25% of restricted stock units (the RSUs) on August 16, 2026. The RSUs were originally granted to the Reporting Person on February 16, 2024. The remaining RSUs vest quarterly in equal installments of 6.25%, with the final vesting date occurring on February 16, 2028, subject to the continued service of the Reporting Person on each such vesting date. These sales are mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a sell to cover transaction and do not represent discretionary trades by the Reporting Person.
- F2 The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $4.29 to $4.39, inclusive. The Reporting Person undertakes to provide to the Issuer, any securityholder of the Issuer, or the staff of the Securities and Exchange Commission (the SEC), upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (2) to this Form 4.
| Open filing 0001801170-26-000207 Read from the filing’s XML Dispute this row |
| 2026-08-12 Filed 2026-08-13 | Soares Karen Officer: Chief Legal Officer | A Grant, award or other acquisition pursuant to Rule 16b-3(d) Class A Common Stock | Acquired (A) | 108,695 | 0 | — | 1,614,217 | Direct (D) | No | F1 - F1 Represents shares of Class A common stock underlying a time-based restricted stock unit award (RSUs). Twenty-five percent of the RSUs will vest on the first anniversary of August 12, 2026, and the remaining RSUs will vest in twelve equal quarterly installments beginning on the date that is three months after the first anniversary of August 12, 2026, in each case subject to the continued service of the Reporting Person on each such vesting date, so that such RSUs will be fully vested on August 12, 2030.
| Open filing 0001999086-26-000023 Read from the filing’s XML Dispute this row |
| 2026-08-12 Filed 2026-08-13 | THORNTON JOSEPH CLAY Officer: Interim CFO | A Grant, award or other acquisition pursuant to Rule 16b-3(d) Class A Common Stock | Acquired (A) | 54,347 | 0 | — | 1,267,301 | Direct (D) | No | F1 - F1 Represents shares of Class A common stock underlying a time-based restricted stock unit award (RSUs). Twenty-five percent of the RSUs will vest on the first anniversary of August 12, 2026, and the remaining RSUs will vest in twelve equal quarterly installments beginning on the date that is three months after the first anniversary of August 12, 2026, in each case subject to the continued service of the Reporting Person on each such vesting date, so that such RSUs will be fully vested on August 12, 2030.
| Open filing 0001801170-26-000202 Read from the filing’s XML Dispute this row |
| 2026-08-10 Filed 2026-08-10 | Toy Andrew Director · Officer: Chief Executive Officer | S Open market or private sale of non-derivative or derivative security Class A Common Stock | Disposed (D) | 87,798 | 4.65 | 408,260.7 Derived: shares × price per share. Exact value 408260.70. | 9,459,316 | Direct (D) | Yes | F1, F2 - F1 The sales reported on this Form 4 represent shares of Class A Common Stock required to be sold by the Reporting Person to cover tax withholding obligations in connection with the final vesting on August 8, 2026 of 6.25% of restricted stock units originally granted to the Reporting Person on August 8, 2022. These sales are mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a sell to cover transaction and do not represent discretionary trades by the Reporting Person.
- F2 The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $4.61 to $4.65, inclusive. The Reporting Person undertakes to provide to the Issuer, any securityholder of the Issuer, or the staff of the Securities and Exchange Commission (the SEC), upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (2) to this Form 4.
| Open filing 0001838733-26-000028 Read from the filing’s XML Dispute this row |
| 2026-07-20 Filed 2026-07-20 | Soares Karen Officer: Chief Legal Officer | S Open market or private sale of non-derivative or derivative security Class A Common Stock | Disposed (D) | 51,700 | 4.51 | 233,167 Derived: shares × price per share. Exact value 233167.00. | 1,505,522 | Direct (D) | Yes | F1, F2 - F1 The sales reported in this Form 4 were effected pursuant to a 10b5-1 plan adopted by the Reporting Person on March 13, 2026.
- F2 The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $4.46 to $4.59, inclusive. The Reporting Person undertakes to provide to the Issuer, any securityholder of the Issuer, or the staff of the Securities and Exchange Commission (the SEC), upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (2) to this Form 4.
| Open filing 0001999086-26-000021 Read from the filing’s XML Dispute this row |
| 2026-07-17 Filed 2026-07-17 | Reynoso Jamie L. Officer: CEO, Medicare Advantage | S Open market or private sale of non-derivative or derivative security Class A Common Stock | Disposed (D) | 4,839 | 4.53 | 21,920.67 Derived: shares × price per share. Exact value 21920.67. | 2,814,640 | Direct (D) | Yes | F1, F2 - F1 The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 12, 2026.
- F2 The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $4.35 to $4.63, inclusive. The Reporting Person undertakes to provide to the Issuer, any securityholder of the Issuer, or the staff of the Securities and Exchange Commission (the SEC), upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (2) to this Form 4.
| Open filing 0001839066-26-000039 Read from the filing’s XML Dispute this row |
| 2026-07-15 Filed 2026-07-16 | Wai Conrad Officer: CEO, Counterpart Health | S Open market or private sale of non-derivative or derivative security Class A Common Stock | Disposed (D) | 24,215 | 4.67 | 113,084.05 Derived: shares × price per share. Exact value 113084.05. | 1,145,699 | Direct (D) | Yes | F1, F2 - F1 The sales reported on this Form 4 represent shares of Class A Common Stock required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of 6.25% of restricted stock units (RSUs) originally granted to the Reporting Person on October 15, 2024. The remaining RSUs vest quarterly in equal installments of 6.25%, with the final vesting date occurring on October 15, 2028, subject to the continued service of the Reporting Person on each such vesting date. These sales are mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a sell to cover transaction and do not represent discretionary trades by the Reporting Person.
- F2 The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $4.67 to $4.73, inclusive. The Reporting Person undertakes to provide to the Issuer, any securityholder of the Issuer, or the staff of the Securities and Exchange Commission (the SEC), upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (2) to this Form 4.
| Open filing 0001801170-26-000178 Read from the filing’s XML Dispute this row |
| 2026-07-15 Filed 2026-07-16 | Reynoso Jamie L. Officer: CEO, Medicare Advantage | S Open market or private sale of non-derivative or derivative security Class A Common Stock | Disposed (D) | 13,119 | 4.67 | 61,265.73 Derived: shares × price per share. Exact value 61265.73. | 2,819,479 | Direct (D) | Yes | F1, F2 - F1 The sales reported on this Form 4 represent shares of Class A Common Stock required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of 6.25% of restricted stock units (the RSUs) on July 15, 2026. The RSUs were originally granted to the Reporting Person on October 15, 2024. The remaining RSUs vest quarterly in equal installments of 6.25%, with the final vesting date occurring on October 15, 2028, subject to the continued service of the Reporting Person on each such vesting date. These sales are mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a sell to cover transaction and do not represent discretionary trades by the Reporting Person.
- F2 The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $4.67 to $4.72, inclusive. The Reporting Person undertakes to provide to the Issuer, any securityholder of the Issuer, or the staff of the Securities and Exchange Commission (the SEC), upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (2) to this Form 4.
| Open filing 0001801170-26-000176 Read from the filing’s XML Dispute this row |
| 2026-07-15 Filed 2026-07-16 | Toy Andrew Director · Officer: Chief Executive Officer | S Open market or private sale of non-derivative or derivative security Class A Common Stock | Disposed (D) | 62,711 | 4.67 | 292,860.37 Derived: shares × price per share. Exact value 292860.37. | 9,547,114 | Direct (D) | Yes | F1, F2 - F1 The sales reported on this Form 4 represent shares of Class A Common Stock required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of 6.25% of restricted stock units (RSUs) originally granted to the Reporting Person on October 15, 2024. The remaining RSUs vest quarterly in equal installments of 6.25%, with the final vesting date occurring on October 15, 2028, subject to the continued service of the Reporting Person on each such vesting date. These sales are mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a sell to cover transaction and do not represent discretionary trades by the Reporting Person.
- F2 The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $4.67 to $4.72, inclusive. The Reporting Person undertakes to provide to the Issuer, any securityholder of the Issuer, or the staff of the Securities and Exchange Commission (the SEC), upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (2) to this Form 4.
| Open filing 0001801170-26-000179 Read from the filing’s XML Dispute this row |
| 2026-07-15 Filed 2026-07-16 | Soares Karen Officer: Chief Legal Officer | S Open market or private sale of non-derivative or derivative security Class A Common Stock | Disposed (D) | 10,519 | 4.67 | 49,123.73 Derived: shares × price per share. Exact value 49123.73. | 1,557,222 | Direct (D) | Yes | F1, F2 - F1 The sales reported on this Form 4 represent shares of Common Stock required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units (RSUs) originally granted to the Reporting Person on October 15, 2024. The remaining RSUs vest quarterly in equal installments of 6.25%, with the final vesting date occurring on October 15, 2028, subject to the continued service of the Reporting Person on each such vesting date. These sales are mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a sell to cover transaction and do not represent discretionary trades by the Reporting Person.
- F2 The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $4.67 to $4.73, inclusive. The Reporting Person undertakes to provide to the Issuer, any securityholder of the Issuer, or the staff of the Securities and Exchange Commission (the SEC), upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (2) to this Form 4.
| Open filing 0001801170-26-000175 Read from the filing’s XML Dispute this row |
| 2026-07-15 Filed 2026-07-16 | THORNTON JOSEPH CLAY Officer: Interim CFO | S Open market or private sale of non-derivative or derivative security Class A Common Stock | Disposed (D) | 4,630 | 4.67 | 21,622.1 Derived: shares × price per share. Exact value 21622.10. | 1,212,954 | Direct (D) | Yes | F1, F2 - F1 The sales reported on this Form 4 represent shares of Class A Common Stock required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of 6.25% of restricted stock units (the RSUs) on July 15, 2026. The RSUs were originally granted to the Reporting Person on October 15, 2024. The remaining RSUs vest quarterly in equal installments of 6.25%, with the final vesting date occurring on October 15, 2028, subject to the continued service of the Reporting Person on each such vesting date. These sales are mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a sell to cover transaction and do not represent discretionary trades by the Reporting Person.
- F2 The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $4.67 to $4.73, inclusive. The Reporting Person undertakes to provide to the Issuer, any securityholder of the Issuer, or the staff of the Securities and Exchange Commission (the SEC), upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (2) to this Form 4.
| Open filing 0001801170-26-000174 Read from the filing’s XML Dispute this row |
| 2026-07-08 Filed 2026-07-09 | Reynoso Jamie L. Officer: CEO, Medicare Advantage | S Open market or private sale of non-derivative or derivative security Class A Common Stock | Disposed (D) | 2,384 | 4.68 | 11,157.12 Derived: shares × price per share. Exact value 11157.12. | 2,832,598 | Direct (D) | Yes | F1 - F1 The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 12, 2026.
| Open filing 0001839066-26-000033 Read from the filing’s XML Dispute this row |
| 2026-07-06 Filed 2026-07-06 | Reynoso Jamie L. Officer: CEO, Medicare Advantage | S Open market or private sale of non-derivative or derivative security Class A Common Stock | Disposed (D) | 6,229 | 5.26 | 32,764.54 Derived: shares × price per share. Exact value 32764.54. | 2,834,982 | Direct (D) | Yes | F1 - F1 The sales reported on this Form 4 represent shares of Class A Common Stock required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of 6.25% of restricted stock units (the RSUs) on July 3, 2026. The RSUs were originally granted to the Reporting Person on January 3, 2023. The remaining RSUs vest quarterly in equal installments of 6.25%, with the final vesting date occurring on January 1, 2027, subject to the continued service of the Reporting Person on each such vesting date. These sales are mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a sell to cover transaction and do not represent discretionary trades by the Reporting Person.
| Open filing 0001839066-26-000031 Read from the filing’s XML Dispute this row |
| 2026-07-01 Filed 2026-07-01 | Toy Andrew Director · Officer: Chief Executive Officer | S Open market or private sale of non-derivative or derivative security Class A Common Stock | Disposed (D) | 313,476 | 5.32 | 1,667,692.32 Derived: shares × price per share. Exact value 1667692.32. | 9,609,825 | Direct (D) | Yes | F1 - F1 The sales reported on this Form 4 represent shares of Class A Common Stock required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of 6.25% of restricted stock units (RSUs) originally granted to the Reporting Person on January 1, 2023. The remaining RSUs vest quarterly in equal installments of 6.25%, with the final vesting date occurring on January 1, 2027, subject to the continued service of the Reporting Person on each such vesting date. These sales are mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a sell to cover transaction and do not represent discretionary trades by the Reporting Person.
| Open filing 0001838733-26-000015 Read from the filing’s XML Dispute this row |
| 2026-06-17 Filed 2026-06-18 | Reynoso Jamie L. Officer: CEO, Medicare Advantage | S Open market or private sale of non-derivative or derivative security Class A Common Stock | Disposed (D) | 2,360 | 4.78 | 11,280.8 Derived: shares × price per share. Exact value 11280.80. | 2,841,211 | Direct (D) | Yes | F1 - F1 The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 12, 2026. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $4.73 to $4.87, inclusive. The Reporting Person undertakes to provide to the SEC staff, the issuer, or any security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
Remarks:
| Open filing 0001839066-26-000024 Read from the filing’s XML Dispute this row |
| 2026-06-16 Filed 2026-06-17 | OLDAKOWSKI JOSEPH FRANK Officer: VP OF FINANCE AND CONTROLLER | S Open market or private sale of non-derivative or derivative security Class A Common Stock | Disposed (D) | 12,102 | 4.86 | 58,815.72 Derived: shares × price per share. Exact value 58815.72. | 299,067 | Direct (D) | Yes | F1 - F1 The sales reported on this Form 4 represent shares of Class A Common Stock required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of 25% of restricted stock units (RSUs) originally granted to the Reporting Person on June 16, 2025. The remaining RSUs vest quarterly in equal installments of 6.25%, with the final vesting date occurring on June 16, 2029, subject to the continued service of the Reporting Person on each such vesting date. These sales are mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a sell to cover transaction and do not represent discretionary trades by the Reporting Person.
| Open filing 0001801170-26-000161 Read from the filing’s XML Dispute this row |
| 2026-06-15 Filed 2026-06-16 | Reynoso Jamie L. Officer: CEO, Medicare Advantage | S Open market or private sale of non-derivative or derivative security Class A Common Stock | Disposed (D) | 6,350 | 4.61 | 29,273.5 Derived: shares × price per share. Exact value 29273.50. | 2,843,571 | Direct (D) | Yes | F1, F2 - F1 The sales reported on this Form 4 represent shares of Common Stock required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units (RSUs). These sales are mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a sell to cover transaction and do not represent discretionary trades by the Reporting Person.
- F2 The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $4.61 to $4.64, inclusive. The Reporting Person undertakes to provide to the Issuer, any securityholder of the Issuer, or the staff of the Securities and Exchange Commission (the SEC), upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (2) to this Form 4.
| Open filing 0001839066-26-000022 Read from the filing’s XML Dispute this row |
| 2026-06-15 Filed 2026-06-16 | Soares Karen Officer: Chief Legal Officer | S Open market or private sale of non-derivative or derivative security Class A Common Stock | Disposed (D) | 4,681 | 4.61 | 21,579.41 Derived: shares × price per share. Exact value 21579.41. | 1,567,741 | Direct (D) | Yes | F1, F2 - F1 The sales reported on this Form 4 represent shares of Common Stock required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units (RSUs). These sales are mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a sell to cover transaction and do not represent discretionary trades by the Reporting Person.
- F2 The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $4.61 to $4.64, inclusive. The Reporting Person undertakes to provide to the Issuer, any securityholder of the Issuer, or the staff of the Securities and Exchange Commission (the SEC), upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (2) to this Form 4.
| Open filing 0001801170-26-000151 Read from the filing’s XML Dispute this row |
| 2026-06-11 Filed 2026-06-11 | Reynoso Jamie L. Officer: CEO, Medicare Advantage | S Open market or private sale of non-derivative or derivative security Class A Common Stock | Disposed (D) | 7,289 | 4.91 | 35,788.99 Derived: shares × price per share. Exact value 35788.99. | 2,849,921 | Direct (D) | Yes | F1 - F1 The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 12, 2026. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $4.79 to $5.15, inclusive. The Reporting Person undertakes to provide to the SEC staff, the issuer, or any security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
Remarks:
| Open filing 0001839066-26-000017 Read from the filing’s XML Dispute this row |
| 2026-05-28 Filed 2026-05-28 | Wai Conrad Officer: CEO, Counterpart Health | S Open market or private sale of non-derivative or derivative security Class A Common Stock | Disposed (D) | 220,426 | 3.99 | 879,499.74 Derived: shares × price per share. Exact value 879499.74. | 1,390,056 | Indirect (I) By Trust. | Yes | F1, F2 - F1 The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 3, 2025. The price reported in Column 4 is an average price. These shares were sold in multiple transactions at prices ranging from $3.92 to $4.04, inclusive. The Reporting Person undertakes to provide to the SEC staff, the issuer, or any security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
- F2 Shares held in trust for the benefit of the Reporting Person's family, of which the Reporting Person is a co-trustee.
| Open filing 0001971702-26-000010 Read from the filing’s XML Dispute this row |
| 2026-05-18 Filed 2026-05-19 | Edwards Carladenise Armbrister Director | S Open market or private sale of non-derivative or derivative security Class A Common Stock | Disposed (D) | 67,160 | 3.42 | 229,687.2 Derived: shares × price per share. Exact value 229687.20. | 285,432 | Direct (D) | No | F1 - F1 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $3.41 to $3.43, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, on request, full information regarding the number of shares sold at each separate price.
| Open filing 0001801170-26-000131 Read from the filing’s XML Dispute this row |
| 2026-05-16 Filed 2026-05-18 | THORNTON JOSEPH CLAY Officer: Interim CFO | F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3 Class A Common Stock | Disposed (D) | 16,942 | 3.47 | 58,788.74 Derived: shares × price per share. Exact value 58788.74. | 1,217,584 | Direct (D) | No | F1 - F1 Represents shares of Class A Common Stock that were automatically withheld to cover tax obligations on May 16, 2026, due to the vesting of 6.25% of the original number of restricted stock units (RSUs) granted to the Reporting Person on February 16, 2024. The remaining RSUs vest quarterly in equal installments of 6.25%, with the final vesting date occurring on February 16, 2028, subject to the continued service of the Reporting Person on each such vesting date.
| Open filing 0001801170-26-000130 Read from the filing’s XML Dispute this row |
| 2026-05-13 Filed 2026-05-13 | Priest Brady Patrick Officer: CEO of Clover Care Services | S Open market or private sale of non-derivative or derivative security Class A Common Stock | Disposed (D) | 98,039 | 3.52 | 345,097.28 Derived: shares × price per share. Exact value 345097.28. | 2,040,222 | Direct (D) | No | — | Open filing 0001938197-26-000011 Read from the filing’s XML Dispute this row |
| 2026-05-08 Filed 2026-05-12 | Toy Andrew Director · Officer: Chief Executive Officer | F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3 Class A Common Stock | Disposed (D) | 85,704 | 2.82 | 241,685.28 Derived: shares × price per share. Exact value 241685.28. | 9,923,301 | Direct (D) | No | F1 - F1 Represents shares of Class A Common Stock that were automatically withheld to cover tax obligations upon the vesting, on May 8, 2026, of 6.25% of the original number of time-based restricted stock units (RSUs) granted to the Reporting Person on August 8, 2022, and timely reported on a Form 4 filed on August 10, 2022. The remaining RSUs vest quarterly in equal installments of 6.25%, with a final vesting date occurring on August 8, 2026, subject to the continued service of the Reporting Person on each such vesting date.
| Open filing 0001801170-26-000123 Read from the filing’s XML Dispute this row |
| 2026-04-18 Filed 2026-04-21 | Priest Brady Patrick Officer: CEO of Clover Care Services | F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3 Class A Common Stock | Disposed (D) | 36,113 | 2.19 | 79,087.47 Derived: shares × price per share. Exact value 79087.47. | 2,138,261 | Direct (D) | No | F1 - F1 Represents shares of Class A Common Stock that were automatically withheld to cover tax obligations upon the vesting, on April 18, 2026, of 6.25% of the original number of time-based restricted stock units (RSUs) granted to the Reporting Person on July 18, 2022, and timely reported on a Form 4 filed on July 19, 2022. The remaining RSUs vest quarterly in equal installments of 6.25%, with the final vesting date occurring on July 18, 2026, subject to the continued service of the Reporting Person on each such vesting date.
| Open filing 0001801170-26-000090 Read from the filing’s XML Dispute this row |
| 2026-04-15 Filed 2026-04-16 | Reynoso Jamie L. Officer: CEO, Medicare Advantage | F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3 Class A Common Stock | Disposed (D) | 12,712 | 2.04 | 25,932.48 Derived: shares × price per share. Exact value 25932.48. | 2,857,210 | Direct (D) | No | F1 - F1 Represents shares of Class A Common Stock that were automatically withheld to cover tax obligations on April 15, 2026, due to the vesting of 6.25% of the original number of restricted stock units (RSUs) granted to the Reporting Person on October 15, 2024, and timely reported on a Form 4 filed on October 17, 2024. The remaining RSUs vest quarterly in equal installments of 6.25%, with the final vesting date occurring on October 15, 2028, subject to the continued service of the Reporting Person on each such vesting date.
| Open filing 0001839066-26-000015 Read from the filing’s XML Dispute this row |
| 2026-04-15 Filed 2026-04-16 | Wai Conrad Officer: CEO, Counterpart Health | F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3 Class A Common Stock | Disposed (D) | 23,463 | 2.04 | 47,864.52 Derived: shares × price per share. Exact value 47864.52. | 1,169,914 | Direct (D) | No | F1 - F1 Represents shares of Class A Common Stock that were automatically withheld to cover tax obligations on April 15, 2026, due to the vesting of 6.25% of the original number of restricted stock units (RSUs) granted to the Reporting Person on October 15, 2024, and timely reported on a Form 4 filed on October 17, 2024. The remaining RSUs vest quarterly in equal installments of 6.25%, with the final vesting date occurring on October 15, 2028, subject to the continued service of the Reporting Person on each such vesting date.
| Open filing 0001971702-26-000007 Read from the filing’s XML Dispute this row |
| 2026-04-15 Filed 2026-04-16 | Toy Andrew Director · Officer: Chief Executive Officer | F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3 Class A Common Stock | Disposed (D) | 60,765 | 2.04 | 123,960.6 Derived: shares × price per share. Exact value 123960.60. | 10,009,005 | Direct (D) | No | F1 - F1 Represents shares of Class A Common Stock that were automatically withheld to cover tax obligations on April 15, 2026, due to the vesting of 6.25% of the original number of restricted stock units (RSUs) granted to the Reporting Person on October 15, 2024, and timely reported on a Form 4 filed on October 17, 2024. The remaining RSUs vest quarterly in equal installments of 6.25%, with the final vesting date occurring on October 15, 2028, subject to the continued service of the Reporting Person on each such vesting date.
| Open filing 0001838733-26-000012 Read from the filing’s XML Dispute this row |
| 2026-04-15 Filed 2026-04-16 | THORNTON JOSEPH CLAY Officer: Interim CFO | F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3 Class A Common Stock | Disposed (D) | 4,158 | 2.04 | 8,482.32 Derived: shares × price per share. Exact value 8482.32. | 1,234,526 | Direct (D) | No | F1 - F1 Represents shares of Class A Common Stock that were automatically withheld to cover tax obligations on April 15, 2026, due to the vesting of 6.25% of the original number of restricted stock units (RSUs) granted to the Reporting Person on October 15, 2024. The remaining RSUs vest quarterly in equal installments of 6.25%, with the final vesting date occurring on October 15, 2028, subject to the continued service of the Reporting Person on each such vesting date.
| Open filing 0001801170-26-000089 Read from the filing’s XML Dispute this row |